Autolomous Ltd.

https://www.autolomous.com

Autolomous LTD is the market leading developer of critical manufacturing management systems for cell and gene therapies. Autolomous internationally deploys fully integrated, digitized and automated supply chain software solutions. These solutions utilize emerging technologies such as Distributed Ledger technology and Internet of Things (IoT) to ensure compliance with current and future regulatory requirements. As a result, Autolomous enables manufacturers to reduce costs and deliver cell & gene therapies to more patients. Autolomous’ platform, AutoloMATE(R) is a business critical robust digital solution increasing efficiency, scalability and process streamlining of the GMP manufacturing and product release of cell and gene therapies. Autolomous LTD is headquartered in London. The company was founded in 2019 by four professionals with combined experience covering fifty years in advanced therapies and medical practice and thirty five years in technology, software and business. *

	Start	2019-01-01 established
	Industry	AutoloMATE® digital solution for GMP manufacturing and product release of CAGTs
	Person	Seyf, Alexander (Autolomous 202110 CEO)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	20-22 Wenlock Road
	City	N1 7GU London
		Address record changed: 2021-10-08

Basic data	Employees	n. a.

		* Document for »About Section«: Autolomous Ltd.. (10/8/21). "Press Release: Autolomous Achieves ISO 27001 and ISO 9001 Certification for Cell and Gene Therapy Management Systems and Services". London.

		Record changed: 2023-07-10

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for Autolomous Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)